|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.460 USD | -4.88% |
|
-16.35% | -42.92% |
| Market Cap | 35.52M 31.04M 28.64M 26.4M 49.76M 3.42B 50.87M 342M 135M 1.68B 133M 130M 5.77B | P/E 2026 * |
-0.82x | P/E 2027 * | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | 12.24M 10.69M 9.87M 9.1M 17.14M 1.18B 17.52M 118M 46.39M 577M 45.96M 44.95M 1.99B | EV / Sales 2026 * |
0.56x | EV / Sales 2027 * | -49.3x |
| Free-Float |
77.71% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Aligos Therapeutics, Inc.
| 1 day | -7.32% | ||
| 1 week | -16.35% | ||
| Current month | -7.80% | ||
| 1 month | -6.50% | ||
| 3 months | -18.28% | ||
| 6 months | -33.58% | ||
| Current year | -42.92% |
| 1 week | 5.32 |  | 6.45 |
| 1 month | 5.26 | | 7.08 |
| Current year | 4.8 | | 10.49 |
| 1 year | 4.8 | | 13.69 |
| 3 years | 3.76 | | 46.8 |
| 5 years | 3.76 | | 449.25 |
| 10 years | 3.76 | | 937.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lawrence Blatt
CEO | Chief Executive Officer | 64 | 04/02/2018 |
Lesley Calhoun
DFI | Director of Finance/CFO | 60 | 31/05/2020 |
Julian Symons
CTO | Chief Tech/Sci/R&D Officer | 65 | 30/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 31/07/2018 | |
K. Hirth
BRD | Director/Board Member | 74 | 31/07/2018 |
Lawrence Blatt
CHM | Chairman | 64 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Director | 5,860 | 0.1088% | ||
| 25/06/26 | Free | Director | 5,860 | 0.1088% | ||
| 25/06/26 | Free | Director | 5,860 | 0.1088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.88% | -16.35% | -38.43% | -78.72% | 35.52M | |
| -0.19% | -3.84% | +0.78% | +2.46% | 49.18B | |
| -0.25% | +1.35% | +385.27% | +595.15% | 39.58B | |
| +0.28% | +3.23% | +7.49% | +62.68% | 34.69B | |
| -1.00% | -1.46% | +28.66% | -9.66% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.47% | 27.11B | |
| +0.10% | -1.53% | - | - | 16.21B | |
| -0.98% | +0.98% | +73.32% | +116.83% | 15.36B | |
| +0.51% | +1.64% | +14.71% | +17.50% | 14.05B | |
| -1.54% | +0.99% | +20.14% | -32.20% | 13.02B | |
| Average | -1.05% | -1.31% | +54.92% | +78.72% | 24.37B | |
| Weighted average by Cap. | -0.29% | -0.18% | +79.98% | +123.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68M 18.94M 17.48M 16.11M 30.37M 2.09B 31.04M 209M 82.18M 1.02B 81.41M 79.62M 3.52B | 5M 4.37M 4.03M 3.72M 7M 482M 7.16M 48.19M 18.96M 236M 18.78M 18.37M 812M |
| Net income | -93.85M -82.02M -75.69M -69.76M -131M -9.04B -134M -905M -356M -4.43B -352M -345M -15.24B | -124M -109M -100M -92.33M -174M -11.96B -178M -1.2B -471M -5.86B -466M -456M -20.17B |
| Net Debt | -23.28M -20.35M -18.78M -17.31M -32.62M -2.24B -33.34M -224M -88.27M -1.1B -87.44M -85.52M -3.78B | -282M -247M -228M -210M -395M -27.17B -404M -2.72B -1.07B -13.31B -1.06B -1.04B -45.81B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$5.460 | -4.88% | 22,707 |
| 17/07/26 | US$5.740 | -0.17% | 47,415 |
| 16/07/26 | US$5.750 | -0.35% | 54,756 |
| 15/07/26 | US$5.770 | -5.49% | 65,307 |
| 14/07/26 | US$6.105 | -4.01% | 102,514 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALGS Stock
Select your edition
All financial news and data tailored to specific country editions
